Optiver Holding
SANA icon

Optiver Holding’s Sana Biotechnology SANA Stock Holding History

Optiver Holding’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Sell
357
-204
-36% -$657 ﹤0.01% 2436
2026
Q1 		$1.62K Buy
561
+52
+10% +$205 ﹤0.01% 1931
2025
Q4 		$2.07K Sell
509
-1,330
-72% -$5.96K ﹤0.01% 1998
2025
Q3 		$6.53K Buy
1,839
+1,822
+10,718% +$6.59K ﹤0.01% 1548
2025
Q2 		$46 Sell
17
-566
-97% -$1.17K ﹤0.01% 1428
2025
Q1 		$979 Buy
+583
New +$1.63K ﹤0.01% 1275
2024
Q3 		– Sell
-117
Closed -$639 – 1072
2024
Q2 		$639 Buy
+117
New +$932 ﹤0.01% 870

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Optiver Holding's SANA Position: Q2 2026 in Review

Optiver Holding reduced its Sana Biotechnology (SANA) stake by 36% in Q2 2026, selling an estimated $657 and leaving 357 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.

Optiver Holding first reported a position in SANA in Q2 2024 and has held it in 7 quarters since. The position peaked at $6.53K in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Optiver Holding held 357 shares of Sana Biotechnology worth $1.25K as of Q2 2026.
  • Optiver Holding sold 204 Sana Biotechnology shares in Q2 2026, an estimated $657.
  • Sana Biotechnology made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2436 holding.
  • Optiver Holding first reported a position in Sana Biotechnology in Q2 2024 and has held it in 7 quarters since.
  • Optiver Holding's Sana Biotechnology position peaked at $6.53K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.